Electronic adherence monitoring identifies severe preschool wheezers who are steroid responsive

Yvonne Bingham1,2, Nina Sanghani2, James Cook1,3

  • 1Department of National Heart and Lung Institute, Imperial College London, UK.

Insights

Adherence to inhaled corticosteroids (ICS) in preschool children with wheeze is often poor. Symptom control improved with ICS, but only in atopic children with good adherence.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology
  • Pharmacology

Background:

  • Preschool troublesome wheeze is common, but adherence to inhaled corticosteroids (ICS) is poorly understood.
  • Children with aeroallergen sensitization or multiple trigger wheeze (MTW) may have better ICS response.

Purpose of the Study:

  • To investigate the relationship between ICS adherence and symptom control in preschool children with troublesome wheeze.
  • To determine if this relationship differs in atopic children or those with MTW.

Main Methods:

  • Recruited 48 preschool children (1-5 years) with recurrent wheeze on ICS.
  • Assessed adherence using electronic monitoring (Smartinhaler).
  • Evaluated symptom control (TRACK), quality of life (PACQLQ), and airway inflammation (exhaled nitric oxide).

Main Results:

  • 50% of children had suboptimal ICS adherence (<80%), with a median adherence of 64%.
  • Overall symptom control and quality of life improved, independent of adherence.
  • Only atopic wheezers with adherence ≥60% showed significant improvement in symptom control (TRACK).

Conclusions:

  • Suboptimal ICS adherence is prevalent in preschool children with troublesome wheeze.
  • Positive association between ICS adherence and symptom control was observed only in atopic wheezers.
  • Assessing adherence is crucial before escalating therapy to identify ICS-responsive phenotypes.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
614
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
620